We are delighted to have acted for a seller financial investor on the sale of its shares in the capital of Fidelis Research to BioIVT, a portfolio company of Linden Capital Partners. Fidelis Research is an innovative, fast-growing biospecimen and clinical trials group of companies, headquartered in Bulgaria, operating across South East Europe.

Our team included Pavel Hristov and Dragomir Stefanov. “We are delighted to have played a lasting role in what will undoubtedly become a benchmark deal in the Bulgarian VC industry”, says Pavel Hristov.

This closed deal follows the successfully completed 25 million Series A round of Alcatraz AI, a high-growth technology firm and an AI specialist, headquartered in the US, with a significant R&D center in Bulgaria. We have advised EBRD as a Bulgarian law counsel, acting alongside a distinguished global law firm, as a lead counsel. Our team included partners Pavel Hristov and Biliana Shagova and Dragomir Stefanov.